Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

Guidance
Cite:

European Centre for Disease Prevention and Control. Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA. 8 September 2022. Stockholm: ECDC; 2022.

This report provides an updated overview of the progress with national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on:
• overall vaccine uptake and uptake by target group;
• vaccination strategies and policies.

Executive summary

Vaccine COVID-19 roll-out overview

  • As of 21 August 2022 (week 33, 2022), over 916 million doses of COVID-19 vaccines had been administered in the EU/EEA, with around 330 million people having received a complete primary course, 243 million having received a first booster dose (30 countries reporting), and 20.7 million having received a second booster dose (25 countries reporting).
  • Since the start of COVID-19 vaccine deployment in December 2020 and as of 21 August 2022, the cumulative uptake of the primary vaccination course against COVID-19 in the total EU/EEA population has reached 72.8% (range: 29.9–86.5%), 53.6% (range: 9.2–71.9%) for the first booster dose and 6.1% for the second booster dose (range: <0.1–16.3%).
  • Among adults (aged 18 years and above) the cumulative vaccine uptake reached 83.5% (range: 35.7−94.6%) for the complete primary course and 64.7% (range: 11.2−86.2%) for the first booster dose. The progress differs across countries, with two countries still reporting less than 50% of the total population having completed the primary vaccination course (Bulgaria and Romania).
  • The uptake of the first booster dose is still showing a very modest increase among adolescents aged 15−17 years and young adults aged 18−24 years (average absolute weekly increase of 0.1% in the last month).
  • The cumulative uptake of the second booster dose among adults aged 18+ is 7.5% (range: <0.1−20.7%), 14.7% in those aged 60+ (range: <0.1−61.7%) and 21.4% in those aged 80+ (range: 0.1−81.2%). The cumulative uptake of the second booster dose among adults aged 18+ is 7.5% (range: <0.1−20.7%), 14.7% in those aged 60+ (range: <0.1−61.7%) and 21.4% in those aged 80+ (range: 0.1−81.2%). The uptake among those aged 60+ is still low in most countries (only seven countries exceeded 25% of those aged 60+ as of week 33, 2022: 61.7% in Sweden; 55.5% in the Netherlands; 51.2% in Ireland, 41.6% in Malta, 34.1% in Luxembourg, 27.8% in France and 26.7% in Iceland).

Vaccination strategies and policies during roll-out

  • All EU/EEA countries offer primary vaccination to those aged 12 years and above. A total of 29 countries are recommending primary vaccination to all children aged 5−11 years and one country is recommending it only for those aged 5−11 years with risk factors.
  • All EU/EEA countries recommend an additional primary dose as an extension of the primary course for those with weakened immune systems. In several countries up to two booster doses are now recommended for immunocompromised individuals.
  • All EU/EEA countries are recommending a first booster dose for different groups in the general population to improve protection in individuals whose immunity may wane overtime after completing the primary course. All EU/EEA countries are recommending first booster doses for all adults aged 18 years and over and fourteen are also recommending first boosters for adolescents between the ages of 12 and 18 years, as authorised by the European Medicines Agency.
  • All EU/EEA countries are now recommending a second booster dose for certain population groups. Country recommendations for a second booster dose target different vulnerable populations, such as people above a certain age threshold (with various age cut-offs from 50+ to 80+ years), residents in long-term care facilities (LTCFs), healthcare workers or personnel working in LTCFs. In some countries individuals aged 18 years and over can also be vaccinated with the second booster dose upon request.
  • Ten EU/EEA countries have published recommendations for their autumn/winter vaccination campaigns, aiming to maximise the benefits of COVID-19 vaccination for those most at risk and older adults who are vulnerable. At the time of this report, sixteen countries were still discussing their vaccination strategies for autumn/winter.
  • Thirteen countries are also considering the possibility of incorporating the autumn/winter COVID-19 vaccination into the annual influenza vaccination campaign.

The roll-out of national vaccination campaigns is an ongoing process, and this report provides a snapshot of the progress to date.

Monitor the COVID-19 vaccine roll-out